Close Menu

NEW YORK – Vermillion said after the close of the market on Tuesday that it has received a notice of non-compliance from Nasdaq indicating that it has failed to meet the requirement that its common stock maintain a minimum closing bid price of $1 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.